BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rincón M, Calpena AC, Clares B, Espina M, Garduño-ramírez ML, Rodríguez-lagunas MJ, García ML, Abrego G. Skin-controlled release lipid nanosystems of pranoprofen for the treatment of local inflammation and pain. Nanomedicine 2018;13:2397-413. [DOI: 10.2217/nnm-2018-0195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Rincón M, Silva-Abreu M, Espinoza LC, Sosa L, Calpena AC, Rodríguez-Lagunas MJ, Colom H. Enhanced Transdermal Delivery of Pranoprofen Using a Thermo-Reversible Hydrogel Loaded with Lipid Nanocarriers for the Treatment of Local Inflammation. Pharmaceuticals (Basel) 2021;15:22. [PMID: 35056079 DOI: 10.3390/ph15010022] [Reference Citation Analysis]
2 Bustos-Salgado P, Andrade-Carrera B, Domínguez-Villegas V, Díaz-Garrido N, Rodríguez-Lagunas MJ, Badía J, Baldomà L, Mallandrich M, Calpena-Campmany A, Garduño-Ramírez ML. Screening Anti-Inflammatory Effects of Flavanones Solutions. Int J Mol Sci 2021;22:8878. [PMID: 34445584 DOI: 10.3390/ijms22168878] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Phadke A, Amin P. A Recent Update on Drug Delivery Systems for Pain Management. J Pain Palliat Care Pharmacother 2021;35:175-214. [PMID: 34157247 DOI: 10.1080/15360288.2021.1925386] [Reference Citation Analysis]
4 Lima FA, Vilela RV, Oréfice RL, Silva IR, Reis EC, Carvalho LA, Maria-Engler SS, Ferreira LA, Goulart GA. Nanostructured lipid carriers enhances the safety profile of tretinoin: in vitro and healthy human volunteers' studies. Nanomedicine (Lond) 2021;16:1391-409. [PMID: 34085552 DOI: 10.2217/nnm-2021-0031] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Mallandrich M, Calpena AC, Clares B, Parra A, García ML, Soriano JL, Fernández-Campos F. Nano-engineering of ketorolac tromethamine platforms for ocular treatment of inflammatory disorders. Nanomedicine (Lond) 2021;16:401-14. [PMID: 33586454 DOI: 10.2217/nnm-2020-0403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luo Y, Yang L, Feng P, Qiu H, Wu X, Lu S, Zhou M, Xu L, Zhu Y. Pranoprofen Nanoparticles With Poly(L-Lactide)-b-Poly(Ethylene Glycol)-b-Poly(L-Lactide) as the Matrix Toward Improving Ocular Anti-inflammation. Front Bioeng Biotechnol 2020;8:581621. [PMID: 33224933 DOI: 10.3389/fbioe.2020.581621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Fonseca-Santos B, Silva PB, Rigon RB, Sato MR, Chorilli M. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Curr Med Chem 2020;27:3623-56. [PMID: 31232233 DOI: 10.2174/0929867326666190624155938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Rincón M, Calpena AC, Fabrega MJ, Garduño-Ramírez ML, Espina M, Rodríguez-Lagunas MJ, García ML, Abrego G. Development of Pranoprofen Loaded Nanostructured Lipid Carriers to Improve Its Release and Therapeutic Efficacy in Skin Inflammatory Disorders. Nanomaterials (Basel) 2018;8:E1022. [PMID: 30544628 DOI: 10.3390/nano8121022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]